Dr. Cliff Olson, Audiologist and founder of Applied Hearing Solutions in Phoenix Arizona, discusses the most recent Clinical Trial News about Frequency Therapeutics and their FX-322 drug that showed no hearing improvement with multiple doses compared to placebo.